HIV Prevention Preparedness Study
What was HPTN 055?
A prospective cohort study to prepare for implementation of HPTN 035, A Phase II/III Safety and Effectiveness Study of the Vaginal Microbicides BufferGel and PRO 2000/5 Gel (P) for the Prevention of HIV Infection in Women
Who participated in the study?
Sexually active HIV-uninfected women from the study sites (240 participants per site)
What happened during the study?
No treatment regimen; however HIV/STD pre-test, risk reduction, and post-test counseling was provided each quarter, and STD treatment was provided as clinically indicated